Granulocyte and monocyte adsorptive apheresis in a case with severe ulcerative colitis unresponsive to conventional medication

Journal of Clinical Apheresis

Volumn 18, Issue 1, 2003, Pages 40-42

  Suzuki, Yasuo ^a,b   Yoshimura, Naoki ^a   Saitoh, Yasushi ^b   Saniabadi, Abby R ^c  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c JAPAN IMMUNORESEARCH LABORATORIES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADSORPTION; ADULT; APHERESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COLONOSCOPY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GRANULOCYTE; HUMAN; MONOCYTE; RELAPSE; REMISSION; TREATMENT FAILURE; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ADSORPTION; ADULT; COLITIS, ULCERATIVE; COLONOSCOPY; CYTAPHERESIS; FEMALE; GRANULOCYTES; HUMANS; MONOCYTES; REMISSION INDUCTION;

EID: 0038076495     PISSN: 07332459     EISSN: None     Source Type: Journal    
DOI: 10.1002/jca.10048     Document Type: Article

References (10)

1. McCarthy DA, Rampton DS, Liu Y-C. Peripheral blood neutrophils in inflammatory bowel disease: morphological evidence of in vivo activation in active disease. Clin Exp Immunol 1991;86:489-493.
2. Mahida YR. The key role of macrophages in the immunopathogenesis of inflammatory bowel disease. Inflamm Bowel Dis 2000;6:21-33.
3. Nikolaus S, Bauditz J, Gionchetti P. Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin-10 during intestinal inflammation. Gut 1998;42:470-476.
4. Tibble JA, Sigthorsson G, Bridger D, Fagerhol MK, Bjarnason I. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 2000;119:15-22.
5. Ohara M, Saniabadi AR, Hirata I, Kasukawa R. Granulocytapheresis in the treatment of patients with rheumatoid arthritis. Artif Organs 1997;21:989-994.
6. Truelove SC, Jewell DP. Intensive intravenous regimens for severe attacks of ulcerative colitis. Lancet 1974;1:1067-1070.
7. Rachmilewitz D (on behalf of an international study group). Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis. Br Med J 1989;298:82-86.
8. Taffet SL, Das KM. Sulphasalazine-adverse effects and desensitization. Dig Dis Sci 1983;28:833-842.
9. Meagher LC, Cousin JM, Seckl JR, Haslett C. Opposing effects of glucocorticoids on the rate of appoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 1996;156:4422-4428.
10. Kashiwagi N, Sawada K, Saniabadi A, Shimoyama T. Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis. Dig Dis Sci 202;47:1334-1341.